Treatment Pathway
Treatment of Conjunctivitis (Pink Eye)
Conjunctivitis is inflammation of the conjunctiva causing redness, discharge, and irritation. Bacterial conjunctivitis produces purulent discharge (antibiotic drops); viral is watery (self-limiting); allergic causes itching (antihistamine drops).
NICE (UK)WHO Clinical GuidelinesAAFP (American Academy of Family Physicians)BMJ Best Practice
Managing Conjunctivitis (Pink Eye) effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Conjunctivitis (Pink Eye) can maintain a good quality of life and prevent serious complications.
First-Line Treatment Principles
- ✓Establish confirmed diagnosis before initiating treatment
- ✓Consider patient preferences, comorbidities, and drug interactions when selecting therapy
- ✓Start at lower doses in elderly, renal impairment, or hepatic impairment; titrate to response
- ✓Review treatment indication at regular intervals; deprescribe when indication resolved
- ✓Lifestyle modification as adjunct or first-line for most chronic conditions
What to Do Now
- Learn your personal risk factors for Conjunctivitis (Pink Eye) (family history, age, lifestyle)
- Attend regular health check-ups and screening tests appropriate for your age and risk
- Track new or changing symptoms, especially those associated with Conjunctivitis (Pink Eye)
- Use our AI symptom checker to assess whether your symptoms fit an early Conjunctivitis (Pink Eye) pattern
- Discuss preventive strategies and early monitoring with your GP
- Build a personalised management plan with your GP or specialist
- Adhere consistently to prescribed medications — do not stop without medical advice
- Adopt a Conjunctivitis (Pink Eye)-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)
Non-Pharmacological Management
- •Diet: evidence-based nutritional approach specific to the condition
- •Regular physical activity: 150 min/week moderate intensity aerobic exercise for most adults
- •Smoking cessation: reduces risk across virtually all disease categories
- •Alcohol restriction: moderate consumption (≤14 units/week) where medically indicated
- •Weight management: maintains BMI 18.5–25 kg/m²
- •Stress management and sleep hygiene
- •Self-management education and patient empowerment
Treatment Goals
🎯Symptom control and quality-of-life improvement
🎯Prevention of complications and disease progression
🎯Minimise treatment burden and adverse effects
🎯Patient-centred shared decision making
Monitoring Parameters
- ◆Condition-specific biomarkers and clinical parameters at each review
- ◆Side effect monitoring according to drug class
- ◆Functional status and quality-of-life assessment
- ◆Treatment adherence: review at every encounter
Red Flags — When to Escalate
- ⚠Any of the characteristic symptoms of Conjunctivitis (Pink Eye) — even mild — in a high-risk individual
- ⚠Progressive worsening of early warning signs over weeks
- ⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
- ⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
- ⚠Strong family history of Conjunctivitis (Pink Eye) combined with new relevant symptoms
- ⚠Sudden worsening of Conjunctivitis (Pink Eye) symptoms despite established treatment
Escalation Criteria
- →Inadequate response after adequate trial period → second-line therapy or specialist referral
- →Adverse drug reactions or tolerance issues → review and switch therapy
- →Acute deterioration or new complications → emergency assessment
Special Populations
Elderly: polypharmacy risk, renal/hepatic dose adjustments, falls risk assessment
Pregnancy: check safety of all medications; specialist review if on multiple agents
Children: weight-appropriate dosing; developmental monitoring
Clinical Insights
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →